课题基金 / 基金详情

Hypoxia-Inducible Factors in Liver Metabolism

Hypoxia-Inducible Factors in Liver Metabolism
肝脏代谢中的缺氧诱导因素
批准号:
7805600
负责人:
Volker Hans Haase
金额:
$36.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-20 至 2014-03-31
关键词:
AcuteAdenovirusesAdultAlbuminsAlcohol consumptionAlcoholic Liver DiseasesApplications GrantsBHLH ProteinBindingBiological ProcessBloodCell LineCell NucleusComplexDataDevelopmentDiabetes MellitusEP300 geneErythropoiesisEventExploratory/Developmental GrantFamilyFatty AcidsFatty LiverFatty acid glycerol estersFundingGene ProteinsGene TargetingGene Transfer TechniquesGenerationsGenesGeneticGenetic TranscriptionGlycolysisGoalsGrantHepaticHepatocyteHomeostasisHomologous GeneHydroxylationHypoxiaHypoxia Inducible FactorHypoxia-Inducible Factor PathwayIn VitroInjuryIronKnock-outKnockout MiceLeadLinkLiverLiver diseasesLungMammalian CellMediatingMediator of activation proteinMetabolicMolecularMusMutant Strains MiceMutationNational Institute of Diabetes and Digestive and Kidney DiseasesNucleic Acid Regulatory SequencesObesityOxygenPathogenesisPatientsPhysiologicalPlayPrimary Cell CulturesProlineProteinsRegulationResponse ElementsRoleSignal TransductionTechnologyTestingTetanus Helper PeptideTetracyclinesTissuesTransferrinTransgenesTransgenic MiceTransgenic OrganismsTumor Suppressor ProteinsVascular Endothelial Growth Factorsadenovirus mediated deliveryadipocyte differentiationangiogenesisbHLH-PAS factor HLFcell typeclinically relevantdeprivationfatty acid metabolismglucose uptakehepatoma cellhuman ARNT proteinhypoxia inducible factor 1in vivoiron metabolismlipid metabolismliver metabolismmembernon-alcoholic fatty livernoveloxidationpromoterprotein expressionpublic health relevancerecombinasetranscription factorubiquitin-protein ligaseuptake

项目摘要

项目成果

Volker Hans Haase的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nonalcoholic fatty liver disease (NAFLD) occurs in patients without significant alcohol consumption and represents a clinico-histopathological entity with histological features that resemble alcohol-induced liver injury. We have used conditional gene targeting in hepatocytes to inactivate the pVHL-E3-ubiquitin ligase, which targets Hypoxia-Inducible-Factor (HIF) for degradation under normoxia. We have discovered that increased HIF activity alters fatty acid metabolism and results in the development of non-alcoholic fatty liver disease in mice. Hypoxia-Inducible Factor-1 and -2 (HIF-1 and HIF-2) are heterodimeric basic-loop-helix transcription factors and are key mediators of cellular adaptation to diminished oxygen supply. Our findings implicate HIF signaling, in particular signaling through HIF-2, in the development of fatty liver disease. In this grant application we propose in vivo and in vitro studies that make use of conditional gene targeting technology and transgenesis to investigate the role of HIF signaling in the regulation of fatty acid uptake, synthesis, beta-oxidation and secretion. Additional in vitro studies are proposed that specifically focus on selected HIF target genes to study their role in lipid metabolism under hypoxia. In Aim 1 we carry out functional studies in VHL mutant mice, in Aim 2 we investigate the role of HIF activation early in the development of steatosis following acute inactivation of pVHL in the adult, and Aims 3 and 4 investigate the role of HIF-2 in a wild type genetic background with a focus on HIF-2 target genes relevant for the development of steatosis. The proposed studies are not only important for our understanding of basic HIF functions in lipid metabolism, but more importantly have direct clinical relevance. We provide a direct molecular link between hypoxic injury and fatty liver development and establish a novel role for the HIF pathway in the pathogenesis of NAFLD. PUBLIC HEALTH RELEVANCE: This grant application examines the role of low oxygen and signaling through Hypoxia-Inducible Factor (HIF) in the regulation of hepatic fatty acid metabolism. The proposal has relevance for all patients with non-alcoholic fatty liver disease, obesity, diabetes and those that suffer from cardio-pulmonary conditions resulting in chronically low blood oxygen levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
Metabolic Reprogramming in Acute Kidney Injury
  • 批准号:
    8930970
  • 项目类别:
  • 资助金额:
    $23.74万
  • 财政年份:
    2014
  • 负责人:
    Volker Hans Haase
  • 依托单位:
Metabolic Reprogramming in Acute Kidney Injury
Metabolic Reprogramming in Acute Kidney Injury
  • 批准号:
    8816559
  • 项目类别:
  • 资助金额:
    $35.33万
  • 财政年份:
    2014
  • 负责人:
    Volker Hans Haase
  • 依托单位:
海外基金